Efficacy of nasal intermittent positive pressure ventilation in treating apnea of prematurity

C. H. Lin, S. T. Wang, Y. J. Lin, T. F. Yeh

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

The efficacy of nasal intermittent positive pressure ventilation (NIPPV) in treating apnea of prematurity was evaluated. Apneic preterm infants were randomly assigned to receive either NIPPV or continuous positive airway pressure (NCPAP) for 4 hr when they failed to respond to conservative therapy. The amount of reduction in apneic spells and bradycardia in the two groups after treatment was compared. Thirty-four infants (18 with NIPPV, 16 with NCPAP) were enrolled. Their birth weights ranged from 590-1,880 g (mean, 1,021 g) and gestational ages from 25-32 weeks (mean, 27.6 weeks). The baseline characteristics were comparable in the two groups. Frequency of apnea and bradycardia was reduced during both forms of treatments. However, the infants receiving NIPPV had a greater reduction of apneic spells (P = 0.02) and a tendency to greater decrease in bradycardia (P = 0.09) than those receiving NCPAP. We conclude that NIPPV is more effective than NCPAP in reducing apnea in preterm infants. NIPPV may reduce bradycardia; however, this needs to be validated by a larger number of observations.

Original languageEnglish
Pages (from-to)349-353
Number of pages5
JournalPediatric Pulmonology
Volume26
Issue number5
DOIs
Publication statusPublished - Dec 1 1998
Externally publishedYes

Fingerprint

Intermittent Positive-Pressure Ventilation
Apnea
Nose
Continuous Positive Airway Pressure
Bradycardia
Premature Infants
Birth Weight
Gestational Age
Therapeutics

Keywords

  • Apnea
  • Nasal intermittent positive pressure ventilation
  • Preterm infants
  • Randomized controlled trial

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Efficacy of nasal intermittent positive pressure ventilation in treating apnea of prematurity. / Lin, C. H.; Wang, S. T.; Lin, Y. J.; Yeh, T. F.

In: Pediatric Pulmonology, Vol. 26, No. 5, 01.12.1998, p. 349-353.

Research output: Contribution to journalArticle

@article{acb9a6d8fb404b0d8b761a93f4a246b6,
title = "Efficacy of nasal intermittent positive pressure ventilation in treating apnea of prematurity",
abstract = "The efficacy of nasal intermittent positive pressure ventilation (NIPPV) in treating apnea of prematurity was evaluated. Apneic preterm infants were randomly assigned to receive either NIPPV or continuous positive airway pressure (NCPAP) for 4 hr when they failed to respond to conservative therapy. The amount of reduction in apneic spells and bradycardia in the two groups after treatment was compared. Thirty-four infants (18 with NIPPV, 16 with NCPAP) were enrolled. Their birth weights ranged from 590-1,880 g (mean, 1,021 g) and gestational ages from 25-32 weeks (mean, 27.6 weeks). The baseline characteristics were comparable in the two groups. Frequency of apnea and bradycardia was reduced during both forms of treatments. However, the infants receiving NIPPV had a greater reduction of apneic spells (P = 0.02) and a tendency to greater decrease in bradycardia (P = 0.09) than those receiving NCPAP. We conclude that NIPPV is more effective than NCPAP in reducing apnea in preterm infants. NIPPV may reduce bradycardia; however, this needs to be validated by a larger number of observations.",
keywords = "Apnea, Nasal intermittent positive pressure ventilation, Preterm infants, Randomized controlled trial",
author = "Lin, {C. H.} and Wang, {S. T.} and Lin, {Y. J.} and Yeh, {T. F.}",
year = "1998",
month = "12",
day = "1",
doi = "10.1002/(SICI)1099-0496(199811)26:5<349::AID-PPUL8>3.0.CO;2-7",
language = "English",
volume = "26",
pages = "349--353",
journal = "Pediatric Pulmonology",
issn = "8755-6863",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Efficacy of nasal intermittent positive pressure ventilation in treating apnea of prematurity

AU - Lin, C. H.

AU - Wang, S. T.

AU - Lin, Y. J.

AU - Yeh, T. F.

PY - 1998/12/1

Y1 - 1998/12/1

N2 - The efficacy of nasal intermittent positive pressure ventilation (NIPPV) in treating apnea of prematurity was evaluated. Apneic preterm infants were randomly assigned to receive either NIPPV or continuous positive airway pressure (NCPAP) for 4 hr when they failed to respond to conservative therapy. The amount of reduction in apneic spells and bradycardia in the two groups after treatment was compared. Thirty-four infants (18 with NIPPV, 16 with NCPAP) were enrolled. Their birth weights ranged from 590-1,880 g (mean, 1,021 g) and gestational ages from 25-32 weeks (mean, 27.6 weeks). The baseline characteristics were comparable in the two groups. Frequency of apnea and bradycardia was reduced during both forms of treatments. However, the infants receiving NIPPV had a greater reduction of apneic spells (P = 0.02) and a tendency to greater decrease in bradycardia (P = 0.09) than those receiving NCPAP. We conclude that NIPPV is more effective than NCPAP in reducing apnea in preterm infants. NIPPV may reduce bradycardia; however, this needs to be validated by a larger number of observations.

AB - The efficacy of nasal intermittent positive pressure ventilation (NIPPV) in treating apnea of prematurity was evaluated. Apneic preterm infants were randomly assigned to receive either NIPPV or continuous positive airway pressure (NCPAP) for 4 hr when they failed to respond to conservative therapy. The amount of reduction in apneic spells and bradycardia in the two groups after treatment was compared. Thirty-four infants (18 with NIPPV, 16 with NCPAP) were enrolled. Their birth weights ranged from 590-1,880 g (mean, 1,021 g) and gestational ages from 25-32 weeks (mean, 27.6 weeks). The baseline characteristics were comparable in the two groups. Frequency of apnea and bradycardia was reduced during both forms of treatments. However, the infants receiving NIPPV had a greater reduction of apneic spells (P = 0.02) and a tendency to greater decrease in bradycardia (P = 0.09) than those receiving NCPAP. We conclude that NIPPV is more effective than NCPAP in reducing apnea in preterm infants. NIPPV may reduce bradycardia; however, this needs to be validated by a larger number of observations.

KW - Apnea

KW - Nasal intermittent positive pressure ventilation

KW - Preterm infants

KW - Randomized controlled trial

UR - http://www.scopus.com/inward/record.url?scp=0032414782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032414782&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1099-0496(199811)26:5<349::AID-PPUL8>3.0.CO;2-7

DO - 10.1002/(SICI)1099-0496(199811)26:5<349::AID-PPUL8>3.0.CO;2-7

M3 - Article

C2 - 9859905

AN - SCOPUS:0032414782

VL - 26

SP - 349

EP - 353

JO - Pediatric Pulmonology

JF - Pediatric Pulmonology

SN - 8755-6863

IS - 5

ER -